Placement of Trials Increasingly Dispersed
The distribution of locations for all trials registered on ClinicalTrials.gov.
The percentage of registered clinical trials being conducted at investigative sites outside of the U.S. continues to rise. According to data provided by http://ClinicalTrials.gov/ on the distribution of locations for all trials registered on the website, 45% reside in non-U.S. geographies.
The U.S., of course, continues to be the most active location for clinical research by size, with the country still home to 40% of all registered studies in the world. Six percent, or 10,572, of those trials in the http://ClinicalTrials.gov/ database have sites located in the U.S. as well as other global regions.
As of Sept. 23, a href="http://www.ClinicalTrials.gov" target="_blank" rel="nofollow">http://ClinicalTrials.gov/ included entries on 175,249 studies, with locations in 187 countries.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
